Hardy B G, Schentag J J
Department of Pharmacy, Sunnybrook Medical Centre, University of Toronto, Canada.
Int J Clin Pharmacol Ther Toxicol. 1988 Aug;26(8):388-91.
The disposition and urinary recovery of unchanged quinidine, (3S)-3-hydroxyquinidine, 2'-oxoquinidinone and quinidine-N-oxide was studied in 5 normal volunteers following a single oral dose of quinidine sulfate (400 mg) with and without cimetidine pre-treatment (1.2 g/day for 7 days). Total amounts of parent compound or metabolites excreted in the urine following cimetidine pre-treatment were not significantly different from that excreted during quinidine alone. Cimetidine reduced the mean apparent oral clearance of quinidine (+/- s.e.m.) by 33% from 23.7 +/- 2.5 to 15.9 +/- 1.7 l/h (p less than 0.05). This 33% decline in oral clearance paralleled the 33% decline in renal clearance of unchanged quinidine which decreased from 56.7 +/- 13.3 to 38.3 +/- 3.3 ml/min. The reduction in quinidine renal clearance associated with cimetidine pre-treatment, although failing to achieve statistical significance, partially accounted for the observed decrease in mean apparent oral clearance. This suggests that cimetidine may compete for renal tubular secretion of unchanged quinidine and its metabolites rather than alter the oxidative metabolism of quinidine.
在5名正常志愿者中,研究了单次口服硫酸奎尼丁(400毫克)且有无西咪替丁预处理(1.2克/天,共7天)后,未变化的奎尼丁、(3S)-3-羟基奎尼丁、2'-氧代奎尼丁酮和奎尼丁-N-氧化物的处置和尿排泄情况。西咪替丁预处理后尿中排泄的母体化合物或代谢物总量与仅使用奎尼丁时排泄的量无显著差异。西咪替丁使奎尼丁的平均表观口服清除率(±标准误)从23.7±2.5降至15.9±1.7升/小时,降低了33%(p<0.05)。口服清除率下降33%与未变化的奎尼丁肾清除率下降33%平行,后者从56.7±13.3降至38.3±3.3毫升/分钟。与西咪替丁预处理相关的奎尼丁肾清除率降低,虽然未达到统计学显著性,但部分解释了观察到的平均表观口服清除率下降。这表明西咪替丁可能竞争未变化的奎尼丁及其代谢物的肾小管分泌,而非改变奎尼丁的氧化代谢。